UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 201,508 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 35.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 365,168 shares of the company's stock after selling 201,508 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 1.22% of Inspire Medical Systems worth $77,069,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Tidal Investments LLC purchased a new position in shares of Inspire Medical Systems in the first quarter valued at $1,151,000. AQR Capital Management LLC grew its stake in shares of Inspire Medical Systems by 152.7% during the second quarter. AQR Capital Management LLC now owns 231,845 shares of the company's stock valued at $31,028,000 after acquiring an additional 140,090 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Inspire Medical Systems during the third quarter worth about $1,929,000. SG Americas Securities LLC lifted its stake in shares of Inspire Medical Systems by 114.2% in the second quarter. SG Americas Securities LLC now owns 6,228 shares of the company's stock worth $833,000 after acquiring an additional 3,321 shares in the last quarter. Finally, Thrivent Financial for Lutherans boosted its holdings in Inspire Medical Systems by 39.7% in the third quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company's stock valued at $23,337,000 after purchasing an additional 31,444 shares during the last quarter. 94.91% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of the business's stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the transaction, the director now owns 23,140 shares in the company, valued at $5,090,800. The trade was a 3.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 4.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

INSP has been the topic of a number of research analyst reports. Stifel Nicolaus reiterated a "hold" rating and set a $200.00 price objective (up from $170.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. KeyCorp decreased their price target on shares of Inspire Medical Systems from $278.00 to $236.00 and set an "overweight" rating for the company in a report on Wednesday, August 7th. Royal Bank of Canada reissued an "outperform" rating and issued a $260.00 target price on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Robert W. Baird raised their price target on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an "outperform" rating in a report on Tuesday, November 5th. Finally, Leerink Partners upped their price objective on Inspire Medical Systems from $167.00 to $197.00 and gave the stock a "market perform" rating in a research note on Tuesday, September 10th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, Inspire Medical Systems has an average rating of "Moderate Buy" and a consensus price target of $233.58.

Inspire Medical Systems Stock Up 1.9 %

Shares of NYSE INSP traded up $3.54 during mid-day trading on Tuesday, hitting $192.06. 396,424 shares of the company traded hands, compared to its average volume of 594,198. Inspire Medical Systems, Inc. has a 1 year low of $123.00 and a 1 year high of $257.40. The stock has a market capitalization of $5.76 billion, a price-to-earnings ratio of 179.35 and a beta of 1.31. The business has a 50 day moving average of $197.40 and a two-hundred day moving average of $176.66.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating analysts' consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The company had revenue of $203.20 million during the quarter, compared to analyst estimates of $197.59 million. During the same period in the prior year, the firm earned ($0.29) earnings per share. The business's quarterly revenue was up 32.6% on a year-over-year basis. As a group, research analysts anticipate that Inspire Medical Systems, Inc. will post 1.33 EPS for the current year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.